Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boehringer ingelheim
3
×
boston blog main
boston top stories
deals
hepatitis b
3
×
life sciences
national blog main
national top stories
alexion pharmaceuticals
boston
clinical trials
eli lilly
indiana blog main
indiana top stories
rna interference
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan aesthetics
alnylam pharmaceutials
alnylam pharmaceuticals
alzheimer's disease
amgen
arrowhead pharmaceuticals
astrazeneca
athira pharma
attralus
biontech
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
covid-19
cullinan oncology
What
dicerna
drug
medicines
pharma
abandoning
acquisitions
ago
baggage
biggest
bio
build
buy
caught
causing
ceo
companies
company’s
cuts
daniel
deal
debut
development
disease
dyne’s
eye
free
gene
gets
gilead
hepatitis
intended
interference
long
microbiome
moves
openly
o’day
pay
pharmaceuticals
pipeline
Language
unset
Current search:
" boehringer ingelheim "
×
" hepatitis b "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M